The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease

Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study

(2010) Daniel Weintraub et al.   ANNALS OF NEUROLOGY

Pathological gambling in Parkinson disease is reduced by amantadine

(2010) Astrid Thomas et al.   ANNALS OF NEUROLOGY

Use of Psychostimulants in Patients with Dementia

(2010) Christian R Dolder et al.   ANNALS OF PHARMACOTHERAPY

Safety and efficacy of sildenafil citrate in the treatment of Parkinson-emergent erectile dysfunction: a double-blind, placebo-controlled, randomized study

(2010) M R Safarinejad et al.   INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH

Antidepressant Drug Effects and Depression Severity

(2010) Jay C. Fournier et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial

(2010) Paolo Barone et al.   LANCET NEUROLOGY

Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial

(2010) Murat Emre et al.   LANCET NEUROLOGY

Rhabdomyolysis after low-dose quetiapine in a patient with Parkinson's disease with drug-induced psychosis: A case report

(2010) Caspar Stephani et al.   MOVEMENT DISORDERS

The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson's disease: A randomized, double-blind, placebo-controlled study

(2010) Endre Pal et al.   MOVEMENT DISORDERS

Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double-blind, randomized, placebo-controlled study (RECOVER)

(2010) Claudia Trenkwalder et al.   MOVEMENT DISORDERS

The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: An international study using the nonmotor symptoms questionnaire

(2010) K. Ray Chaudhuri et al.   MOVEMENT DISORDERS

The nonmotor symptoms of Parkinson's disease-An overview

(2010) Shen-Yang Lim et al.   MOVEMENT DISORDERS

Treatment of insomnia in Parkinson's disease: A controlled trial of eszopiclone and placebo

(2010) Matthew Menza et al.   MOVEMENT DISORDERS

Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease

(2010) D. Weintraub et al.   NEUROLOGY

Practice Parameter: Treatment of nonmotor symptoms of Parkinson disease: Report of the Quality Standards Subcommittee of the American Academy of Neurology

(2010) T. A. Zesiewicz et al.   NEUROLOGY

Glycopyrrolate for sialorrhea in Parkinson disease: A randomized, double-blind, crossover trial

(2010) M. E. L. Arbouw et al.   NEUROLOGY

Double-blind, randomized, placebo controlled trial on the effect of 10 days low-frequency rTMS over the vertex on sleep in Parkinson’s disease

(2010) Pablo Arias et al.   SLEEP MEDICINE

A randomized controlled trial of quetiapine for psychosis in Parkinson’s disease

(2010) Paul Shotbolt   Neuropsychiatric Disease and Treatment

Using Modafinil to Treat Fatigue in Parkinson Disease

(2009) Jau-Shin Lou et al.   CLINICAL NEUROPHARMACOLOGY

QUETIAPINE IMPROVES VISUAL HALLUCINATIONS IN PARKINSON DISEASE BUT NOT THROUGH NORMALIZATION OF SLEEP ARCHITECTURE: RESULTS FROM A DOUBLE-BLIND CLINICAL-POLYSOMNOGRAPHY STUDY

(2009) HUBERT H. FERNANDEZ et al.   INTERNATIONAL JOURNAL OF NEUROSCIENCE

Modafinil for Parkinson’s disease fatigue

(2009) Hilary L. Tyne et al.   JOURNAL OF NEUROLOGY

Long-lasting benefits of botulinum toxin type B in Parkinson’s disease-related drooling

(2009) Giovanni Lagalla et al.   JOURNAL OF NEUROLOGY

Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial

(2009) Dag Aarsland et al.   LANCET NEUROLOGY

Randomized controlled trial of memantine in dementia associated with Parkinson's disease

(2009) Iracema Leroi et al.   MOVEMENT DISORDERS

The effect of psychotherapy in patients with PD: A controlled study

(2009) Erika Sproesser et al.   PARKINSONISM & RELATED DISORDERS

Botulinum toxin B as an effective and safe treatment for neuroleptic-induced sialorrhea

(2009) Susanne Steinlechner et al.   PSYCHOPHARMACOLOGY

Depression in Parkinson's disease: A double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation

(2008) Ticyana Moralez da Silva et al.   JOURNAL OF AFFECTIVE DISORDERS

Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: A double-blind, randomized, placebo-controlled study

(2008) David Devos et al.   MOVEMENT DISORDERS

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

(2008) Christopher G. Goetz et al.   MOVEMENT DISORDERS

A controlled trial of antidepressants in patients with Parkinson disease and depression

(2008) M. Menza et al.   NEUROLOGY

Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review)

(2008) M. Naumann et al.   NEUROLOGY

Neuropsychological Characteristics of Dementia with Lewy Bodies and Parkinson’s Disease with Dementia: Differentiation, Early Detection, and Implications for “Mild Cognitive Impairment” and Biomarkers

(2008) Alexander I. Tröster   NEUROPSYCHOLOGY REVIEW

Use of antipsychotics in elderly patients with dementia: Do atypical and conventional agents have a similar safety profile?

(2008) G TRIFIRO et al.   PHARMACOLOGICAL RESEARCH

Visual impairment in Parkinson's disease treated with amantadine: Case report and review of the literature

(2007) Shin-ichiro Kubo et al.   PARKINSONISM & RELATED DISORDERS